Join us for our upcoming webinar in June! 🗓️ 🔬 June 14: "Demonstrating the Interference of Tissue Processing in the Evaluation of Tissue Biomarkers: The Case of PD-L1" with Dr. Catarina Eloy and her valuable contribution, with Prof. Claudio Doglioni as Moderator.. Gain valuable insights into how tissue processing can impact biomarker evaluation, with a focus on PD-L1 analysis. Register here: 👉 June 14: Webinar Registration https://lnkd.in/dSGjCdiP Don't miss this opportunity to enhance your knowledge and stay updated with the latest developments in tissue biomarker evaluation. #DiapathWebinar #TissueProcessing #Biomarkers #PDL1 #HER2 #BreastCancer #MedicalWebinar #PathologyEducation
Diapath S.p.A’s Post
More Relevant Posts
-
🔬 New Research Spotlight: Custom Assay Solutions in Action 🔬 We’re excited to share a recent publication from Ashcroft et al., who partnered with our custom assay development team to leverage an antibody-based approach for examining transcription and translation changes. Their work focused on thiazolyl ketone inhibitors of cPLA2α, uncovering a novel compound that may help treat cancers by modulating oxidative stress. 👏 Congratulations to Ashcroft et al. on these exciting findings! 👏 Want to learn more? Read the full publication here: https://hubs.ly/Q031n0_F0 #RNAResearch #BiotechInnovation #CancerResearch #DrugDiscovery #Eclipsebio
To view or add a comment, sign in
-
-
OMPRN is excited to share with you our new 'understanding biomarkers' graphic series. Here is the 4th biomarker: Therapeutic Biomarkers! Terms you should know: ✨ Biomarker - A biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease. A biomarker may be used to see how well the body responds to a treatment for a disease or condition. Also called molecular marker and signature molecule. Be sure to keep an eye out for the rest of the series and to consult our website for our enhanced glossary as well as some more resources! #cancereducation #biomarkers #understandingbiomarkers
To view or add a comment, sign in
-
-
Are you writing a grant that relies on quality cytometry data and need support? We have compiled a set of relevant documentation and materials to help with your research and instrumentation grant applications. Since CyTOF XT™ can simplify your ability to deeply interrogate millions of individual cells, the technology can be applied to identify biomarkers, predict therapeutic response and profile immune cell functionality. Feel free to leverage these resources: https://lnkd.in/gpFHhNYg #grant #resources #globalsupport #cytometry #immuneprofiling
To view or add a comment, sign in
-
-
Digital PCR is a precise technique for identifying and quantifying nucleic acids by determining precise molecule amounts through statistical methods. Digital PCR allows for precise, fast, and straightforward detection of molecules. Also, it has higher sensitivity and facilitates absolute quantification of molecule levels. 🧪🧬 Technological advancements, which have improved the precision and sensitivity of nucleic acid quantification, drive the market demand. Besides, the increasing prevalence of cancer is anticipated to have a significant impact on market expansion. 🔬📈 The proficient team at Polaris Market Research has done an in-depth analysis of the digital PCR market. Our comprehensive research report thoroughly examines the market and covers all your needs. 𝐕𝐢𝐬𝐢𝐭 𝐨𝐮𝐫 𝐰𝐞𝐛𝐬𝐢𝐭𝐞 𝐭𝐨 𝐠𝐞𝐭 𝐚 𝐟𝐫𝐞𝐞 𝐬𝐚𝐦𝐩𝐥𝐞 𝐨𝐟 𝐭𝐡𝐞 𝐫𝐞𝐩𝐨𝐫𝐭 𝐧𝐨𝐰! 💻📃 https://lnkd.in/deyaiSsj #digitalpcr #healthcare #polymerasechainreactionmarket #clinicaldiagnostics #polarismarketresearch
To view or add a comment, sign in
-
-
In a recent Q&A, Dr. Michelle Ting-Lin, Medical Director of Clinical Development at Tempus, provides insights into the science behind the Immune Profile Score (IPS), a novel biomarker designed to enhance the identification of patients who may benefit from immune checkpoint inhibitor (ICI) therapies. Read here: https://tempus.co/4i9EftN
To view or add a comment, sign in
-
-
🚀 Today is the day! The Cydem VT from Beckman Coulter Life Sciences has been revealed! The Cydem VT Automated Cell Culture System is a cutting-edge platform that integrates multiple Beckman Coulter Life Sciences technologies to streamline and enhance cell line development. Lab managers can now benefit from a higher-throughput method for top clone screening, ensuring that no promising clones are overlooked in the critical process of consistently selecting the best. New therapeutic antibodies for cancer and autoimmune diseases can now be discovered more quickly with this new system, revolutionizing how labs approach breakthrough research. As part of the team, I had the privilege of helping design and build the software that powers this advanced system. 💻 It's exciting to see how the platform will transform workflows, offering increased confidence in results. The key technologies behind this innovation include: - Biomek workstation - Biolector XT Microbioreactor - Vi-Cell Blu Cell Counter - Valita Titer Assay Check out more details on Beckman Coulter’s official website: https://lnkd.in/gs2vrvYJ Plus, there’s a great tutorial video that dives into how the product works. 🔬 #biomek #beckmancoulter #celllinedevelopment #cellculture #bioreactor
To view or add a comment, sign in
-
-
Since this flagship product was launched in the United States in April 2023, it has become extremely popular. It is compact and convenient; once you’ve used it for RNA/DNA extraction, you won’t want to spend time and effort doing it manually again. It’s so simple—just place your processed sample in the first deep well, select the program, and start. The adaptability is remarkable, as it can extract from nearly all sample types (over 90%), including blood, tissue, saliva, hair, soil, and environmental samples. The NIH has purchased more than ten units, along with institutions like Lilly, HDB, UCSD, PITT, and cancer centers. If your lab or company involves nucleic acid extraction, I highly recommend scheduling a demo of this fully automated nucleic acid extractor.
To view or add a comment, sign in
-
-
Join me and Dr Hanan today for an interesting discussion about novel blood based biomarkers for the diagnosis of Alzheimer’s Disease as well as breakthrough advances in treating the disease
Join our experts for the first session of the National Reference Laboratory (NRL) #FocusOnseries! Dr. Fatma Ridene, Dr. Laila AbdelWareth, and Dr. Hanan Ibrahim take a deep dive into Alzheimer’s diagnostics, focusing on risk factors, novel biomarkers, and exploring innovative therapeutic interventions. Get in-depth insights on Wednesday, August 7th, from 3–4 PM. Register today: https://bit.ly/4fr0Pgh
To view or add a comment, sign in
-
-
#USCAP (2025) - 2/3 ABSTRACTS ACCEPTED FOR POSTER PRESENTATION: >Histologic Analysis and Clinical Correlation of Normal Gastric Mucosa and Mild Chronic Gastritis >Correlation of Breast Biomarkers with those of Oncotype DX: A Community Hospital Quality Improvement Study
To view or add a comment, sign in
-
-
Excited to have you speaking at this year's Retinal Imaging Biomarkers & Endpoints meeting, Yasin! If you're interested in learning more about Yasin's full presentation details, you can do so here - https://ter.li/p4jllc #retinalimaging #ophthalmicimaging
I am excited to be speaking at the 2nd Retinal Imaging Biomarkers & Endpoints Summit this June 25-27 in Boston, MA! I will be presenting on Functional Testing in Clinical Trials for Geographic Atrophy. Will you be joining me there? Learn more about the conference here: https://ter.li/p4jllc
To view or add a comment, sign in